Official title: Effect of Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section Summary: This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate. Conditions: Virtual Reality, Dexmedetomidine, Maternal Anxiety, Stress, Hemodynamics, Neonatal Outcomes, Cesarean Section Study type: INTERVENTIONAL Primary purpose: TREATMENT Phases: NA Enrollment: 52 (ESTIMATED) Status: RECRUITING Completion: 2026-07-01 (ESTIMATED)
ClinicalTrials.gov published a clinical update in Critical Care on 21 Jan 2026.
The item focuses on Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section.
Review the original article for the full source wording and details.